The 20 Best Hereditary Paraganglioma-Pheochromocytoma Syndrome Doctors Near Me in Ann Arbor, MI

Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is rated as a Distinguished provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. He is also highly rated in 105 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy. Dr. Else is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Gary D. Hammer, M.D., Ph.D. is Professor in Departments of InternalMedicine (MEND), Cell & Developmental Biology, and Molecular &Integrative Physiology. He currently serves as Director of EndocrineOncology Program in Rogel Cancer Center where he holds the MillieSchembechler Professorship in Adrenal Cancer. He is past Director ofCenter for Organogenesis: Stem Cells & Regenerative Medicine. He hasbrokered the recent renaissance of the current Michigan team of adrenalscientists that includes a who’s who in the study of adrenal disease.He received the UofM Jerome Conn Award for Outstanding Research inInternal Medicine, the Endocrine Society Edwin B. Astwood Award forOutstanding Research and is a member of ASCI and AAP. He has served innumerous leadership roles at UofM and in the public and private sectorsincluding recent tenure on Board of Scientific Advisors for NCI. He isthe editor of four textbooks including Pathophysiology of Disease: AnIntroduction to Clinical Medicine (McGraw Hilll), and the upcomingAdrenal Section Editor for Degroot’s Endocrinology (Elsevier). He hasserved in numerous capacities for the world’s largest endocrineorganization, the Endocrine Society including his most recent role asPresident of the Society (2020-2021). An Advisor to the CongressionalH.E.L.P. committee - he co-authored the 21st Century Cancer ALERT(Access to Life-Saving Early detection, Research and Treatment) Act’’ lintroduced in Congress in 2009. He has been catalyst for the formationof two international cooperative groups, most recently the A5 (AmericanAustralian Asian Adrenal Alliance) that leverages collaboration tosecure projects from Pharma and funding agencies across the spectrum ofadrenal diseases. He is a cofounder of two companies - MILLENDO andSLING THERAPEUTICS that focus on rare endocrine diseases. Dr. Hammer is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Neuroblastoma, and Hereditary Neuroblastoma. Dr. Hammer is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Richard Auchus is a professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND) and Chief of the Endocrinology & Metabolism Section at the Ann Arbor VA Medical Center. He received his medical degree and Ph.D. in pharmacology from Washington University in St. Louis. Then Dr. Auchus completed a residency at the University of Iowa and an endocrinology fellowship at UTHSC-San Antonio/Wilford Hall Medical Center. Dr. Auchus came to UMHS from the Graduate School of Biomedical Sciences in Southwestern Medical School, University of Texas, where he was a Professor of Internal Medicine - Endocrinology.Dr. Auchus is a steroid biologist with expertise both in basic science and clinical/translational science. His work has included translational research into: molecular and genetic mechanisms of human hypertension, improved diagnostic studies and management in primary aldosteronism and Cushing syndromes, modifier genes in 21-hydroxylase deficiency, cardiovascular disease in polycystic ovary syndrome, and the endocrinology of traumatic brain injury. Dr. Auchus is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Congenital Adrenal Hyperplasia (CAH), Intersex, Cushing's syndrome, Hormone Replacement Therapy (HRT), and Orchiectomy. Dr. Auchus is board certified in Endocrinology, Diabetes & Metabolism.

Cristina Nieves is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Nieves is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Toxic Nodular Goiter, Thyroid Storm, Type 2 Diabetes (T2D), and Low Blood Sugar. Dr. Nieves is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Chun is a physician-scientist, who practices general endocrinology, including diabetes, thyroid diseases, and metabolic syndrome. His research is focused on the cellular and molecular mechanism of obesity, diabetes, and inflammatory and fibrotic tissue damages in endocrine disorders, such as Graves’ eye disease. Dr. Chun is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, and Familial Isolated Hyperparathyroidism. Dr. Chun is board certified in Endocrinology, Diabetes & Metabolism and Internal Medicine.

Merve Kutahyalioglu M.D., is a Clinical Assistant Professor in the Division of Metabolism, Endocrinology, and Diabetes. She completed her internal medicine internship and residency at the University of Texas Health Science Center, and endocrinology fellowship training at the Baylor College of Medicine. She is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism. Dr. Kutahyalioglu joined the faculty at the University of Michigan in 2021. She has an interest in general endocrinology. She is a part of the care team in the MEND Weight Management and MEND Post-Bariatric Surgery Care Program. Dr. Kutahyalioglu is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Malnutrition, Type 1 Diabetes (T1D), Obesity in Children, and Hyperparathyroidism. Dr. Kutahyalioglu is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule. Dr. Sandouk is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Jennifer Iyengar is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Iyengar is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Thyroid Nodule, Paget's Disease of Bone, and Type 2 Diabetes (T2D).

Joanna Spencer is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Spencer is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. She is also highly rated in 35 other conditions, according to our data. Her clinical expertise encompasses Ectopic Cushing's syndrome, Cushing's syndrome due to Adrenal Tumor, Cushing's syndrome, and Exogenous Cushing's syndrome.

Dr. Bodnar is the Assistant Chief of Endocrinology & Metabolism at Ann Arbor VA Health System. He is a graduate of the University of Michigan Medical School, and completed Internal Medicine Residency and Chief Residency, as well as his Fellowship in Endocrinology at Michigan Medicine. From 2014-2021 he was in private practice at Ann Arbor Endocrinology & Diabetes and was a Key Clinical Faculty Member in the St. Joseph Mercy Ann Arbor Internal Medicine Residency. Dr. Bodnar is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Osteoporosis, and Pituitary Tumor. Dr. Bodnar is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Craig Jaffe is Associate Professor of Internal Medicine and Clinical Section Chief in the Division of Metabolism, Endocrinology & Diabetes (MEND). He is also the Endocrine Section Chief at the VA Ann Arbor Healthcare System. Dr. Jaffe is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Hypogonadism, Isolated Hypogonadotropic Hypogonadism, Kallmann Syndrome, and Pediatric Growth Hormone Deficiency. Dr. Jaffe is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Susan Pitt, MD, MPHS is an Associate Professor of Surgery and Director of the Endocrine Surgery Health Services Research Program in the Department of Surgery at Michigan Medicine. Dr. Pitt graduated Magna Cum Laude with a B.A. in psychology from Boston College in Chestnut Hill, MA. She received her medical degree from the Medical College of Wisconsin and a Masters degree in Population Health Science from Washington University in St. Louis which was supported by a scholarship from the BJC Healthcare Institute for Public Health. Dr. Pitt completed her general surgery residency at Washington University in St. Louis with Alpha Omega Alpha honors and was both the resident representative and administrative chief resident. During a two-year post-doctoral research fellowship at the University of Wisconsin, she was awarded a Ruth L. Kirschstein T32 training grant from the National Institutes of Health and the American College of Surgeons Resident Research Scholarship to study signaling pathways in neuroendocrine cancers. Following residency, Dr. Pitt completed an Endocrine Surgery Fellowship at Brigham & Women’s Hospital in Boston, MA before serving as an Assistant Professor of Surgery for six years at the University of Wisconsin in Madison, WI. Dr. Pitt joined the faculty of the University of Michigan in 2021.Dr. Pitt has received multiple awards for her clinical, research, and teaching efforts including the American Medical Women’s Association Exceptional Mentor Award in 2018 and an award from the University of Wisconsin-Madison Women in Science & Engineering Leadership Institute. She is a Fellow of the American College of Surgeons and active member of multiple organizations including the Association of Academic Surgery, Society of University Surgeons, American Association of Endocrine Surgeons, American Thyroid Association, Surgical Outcomes Club, Association of Women Surgeons, and Society for Medical Decision Making.Clinical Specialization: Dr. Pitt’s clinical interests include surgical diseases of the endocrine system including the thyroid, parathyroid, and adrenal glands. She has a particular interest and experience in the diagnosis and treatment of papillary thyroid cancer, functional adrenal tumors, and complex parathyroid disease. Dr. Pitt works closely with her endocrine oncology partners to provide excellent patient care and outcomes. Dr. Pitt is rated as an Advanced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Hyperparathyroidism, Papillary Thyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Pitt is board certified in Surgery.

Dr. Underwood is a fellowship-trained endocrine surgeon whose practice is dedicated to the surgical management of thyroid, parathyroid, and adrenal gland disorders. He performs more than 350 endocrine operations each year, making him one of the highest-volume endocrine surgeons in the region. His practice includes a strong focus on complex reoperative thyroid and parathyroid procedures as well as the treatment of advanced thyroid cancer.Dr. Underwood earned his medical degree from the Indiana University School of Medicine, where he was inducted into the Alpha Omega Alpha Honor Medical Society and received the Rosenbower Award in Surgery, given to the top graduating student pursuing a surgical career. He completed his general surgery residency at NYU Langone Health/Bellevue Hospital in New York City and a clinical fellowship in endocrine surgery at the University of Michigan.He holds a Focused Practice Designation (FPD) in Adult Complex Thyroid and Parathyroid Surgery from the American Board of Surgery - an advanced credential recognizing surgeons who demonstrate exceptional case volume, technical expertise, and a multidisciplinary approach to the care of patients with complex endocrine disorders. Fewer than 400 surgeons in the United States currently hold this designation, underscoring his commitment to maintaining a high level of specialization and quality in thyroid and parathyroid surgery.Dr. Underwood is board-certified in general surgery and an active member of the American Association of Endocrine Surgeons and the American College of Surgeons. His practice is centered on delivering safe, effective, and thoughtful surgical care, with an emphasis on collaboration, communication, and long-term patient outcomes. Dr. Underwood is rated as an Advanced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Thyroid Cancer, Osteitis Fibrosa, Thyroidectomy, and Parathyroidectomy. Dr. Underwood is board certified in Surgery.

Dr. Gauger is the William J. Fry Professor of Surgery in the Division of Endocrine Surgery. Dr. Gauger trained in General Surgery at the University of Michigan where he also completed fellowships in Extracorporeal Life Support and Surgical Critical Care. After graduation, he served as the T.S. Reeve International Fellow in Endocrine Surgery at the Royal North Shore Hospital in Sydney, Australia. He then returned to Michigan in 1999 to join the faculty in the Department of Surgery. Dr. Gauger specializes in the treatment of benign and malignant diseases of the thyroid, parathyroid, and adrenal glands in both adults and children. He also specializes in the treatment of endocrine tumors of the pancreas and intestines. He has a particular interest in the Multiple Endocrine Neoplasia Syndromes. Dr. Gauger is also a Professor of Learning Health Sciences and is deeply involved in graduate medical education issues. He serves as the Program Director for Surgery and leads the Norman W. Thompson Fellowship in Endocrine Surgery. He was also the founding Executive Director of the University of Michigan Clinical Simulation Center. Dr. Gauger is rated as an Advanced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Thyroid Cancer, Parathyroid Hyperplasia, Parathyroidectomy, and Thyroidectomy. Dr. Gauger is board certified in Surgery.

Noura Nachawi is an Endocrinologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 17 years. Dr. Nachawi is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Hypercalcemia, Milk-Alkali Syndrome, Low Blood Sugar, and Hyperparathyroidism.

Sima Saberi is an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Saberi is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Diabetic Nephropathy, Type 1 Diabetes (T1D), Osteoporosis, and Thyroidectomy.

Shafaq Khairi is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Khairi is rated as an Advanced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. She is also highly rated in 40 other conditions, according to our data. Her clinical expertise encompasses Hyperaldosteronism, Familial Hyperaldosteronism, Multiple Endocrine Neoplasia Type 1, and Hyperparathyroidism.

David Hughes is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Hughes is rated as an Advanced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Familial Isolated Hyperparathyroidism, Parathyroid Hyperplasia, Osteitis Fibrosa, Parathyroidectomy, and Thymectomy.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as an Experienced provider by MediFind in the treatment of Hereditary Paraganglioma-Pheochromocytoma Syndrome. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.